DEVELOPMENT OF NANOPARTICLE SYNTHESIS FOR PACLITAXEL DELIVERY IN LUNG CANCER THERAPY

Vol 2, 2024 - 314787
Abstract
Favorite this paper
How to cite this paper?
Abstract

Lung cancer is a highly prevalent and lethal neoplasm. Its high mortality rate is primarily due to its diagnosis at advanced stages, which significantly reduces patient survival time. Nanomedicine therapeutic alternatives aimed at minimizing the side effects and enhancing treatment efficacy. This study explores nanoemulsion and nanoprecipitation synthesis methods to develop a nanosystem using the biocompatible copolymer poly(lactic-co-glycolic acid) (PLGA) for paclitaxel delivery. Our findings reveal that nanoparticles produced via the nanoemulsion technique had an average diameter of 210 ± 2 nm, a polydispersity index (PDI) of 0.14 ± 0.02, a zeta potential of -8.7 ± 0.8 mV, and an encapsulation efficiency of 58%. In contrast, nanoparticles synthesized using the nanoprecipitation technique exhibited sizes of ca. 370 ± 90 nm, a PDI of 0.67 ± 0.04, and a zeta potential of -20 ± 8 mV. The latter formulation presented aggregation over time, which negatively affects their stability and circulation time in vivo. Additionally, these nanoparticles will be subjected to scanning electron microscopy, cytotoxicity assays, and cell internalization studies to assess their morphology, safety profile, and in vitro toxicity. Our findings may represent a promising and safe alternative for lung cancer therapy.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade de São Paulo
Track
  • 4. Bioengineering and Biomaterial
Keywords
polymeric nanoparticles
lung cancer
paclitaxel
PLGA
therapy